期刊文献+

乳腺癌耐药蛋白在乳腺癌和乳腺良性病变组织中的表达 被引量:3

Expressions of Breast Cancer Resistance Protein (BCRP) in Breast Cancer and Benign Lesion
下载PDF
导出
摘要 [目的]检测乳腺癌耐药蛋白(BCRP)在乳腺癌和乳腺良性病变组织中的表达及临床意义。[方法]通过流式细胞仪检测31例原发乳腺癌组织、25例乳腺良性病变标本和16例正常对照乳腺组织中BCRP的表达。[结果]BCRP在乳腺癌组织(0.282581±0.183686)和乳腺良性病变组织(0.2068±0.037723)中的表达差异不显著,而BCRP在乳腺癌组织和乳腺良性病变组织中的表达高于正常对照组(0.03125±0.000905),差异有显著性。乳腺癌组织BCRP与ER、PR阴阳性、CerbB鄄2阴阳性、EGFR阴阳性值均数比较差异均不显著。[结论]BCRP在正常乳腺组织中少量表达,乳腺良性疾病组织中较高表达,而乳腺癌组织中异常表达。BCRP是独立于ER、PR、CerbB-2、EGFR的细胞膜蛋白。
机构地区 金华市中心医院
出处 《中国肿瘤》 CAS 2005年第5期336-338,共3页 China Cancer
基金 2002年金华市科技重点创新项目
  • 相关文献

参考文献8

  • 1毛友生,Austin Doyle,Weidong Yang,Yuetong Wei,Mark J.Krasna,Douglas D.Ross.BCRP基因在非小细胞肺癌组织和非癌肺组织中的表达及意义[J].癌症,2001,20(3):274-278. 被引量:9
  • 2Doyle LA, Yang W, Abruzzo LV,et al. A muhidrug resistance transporter from human MCF-7 breast cancer cells[J]. Proc Natl Acad Sci USA, 1998,95(26): 15665-15670.
  • 3Scheffer GL, Maliepaard M, Pijnenborg AC, et al. Breast cancer resestance protein is locaoized at the plasma membrance in mitoxantrone and topotecan-resistant cell lines[J]. Cancer Res,2000,60(10):2589-2593.
  • 4Rocchi E, Khod akovA, Volk EL, et al. The product of the ABC helf-transporter gene ABCG 2 (BCRP/mxp/ABCP)is expressed in the plasma membrane [J]. Biochem Biophys Res Commun, 2000,27(1):42-46.
  • 5Maliepard M, Scheffer GL, Faneyte IF, et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues [J].Cancer Res, 2001,61:3458-3464.
  • 6管俊,盛瑞兰,顾健.急性非淋巴细胞性白血病患者乳腺癌耐药蛋白基因表达及其临床意义[J].白血病.淋巴瘤,2002,11(3):139-142. 被引量:6
  • 7孙宇萍,王树滨,陈亦欣,徐敏,刘雅洁,陈伟.乳腺癌耐药蛋白在乳腺癌组织中的表达及其与预后的关系[J].中国癌症杂志,2004,14(2):123-126. 被引量:16
  • 8Kanzaki A, Toi M, Nakayama K, et al. Expression of multidrug resistance-related transporters in human breast carcinoma [J]. Jpn J Cancer Res, 2001,92:452-458.

二级参考文献16

  • 1Whelan RD, Hill BT. Differential expression of steroid receptors, hsp27, and pS2 in a series of drug resistant human breast tumor cell lines derived following exposure to antitumor drugs or to fractionated X-irradiation[J]. Breast Cancer Res Treat, 1993,2
  • 2Sargent JM, Williamson CJ, Maliepaard M, et al. Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia [J]. Br J Haematol,2001,115(2): 257-262.
  • 3Bailey-Dell K J, Hassel B, Doyle LA, et al. Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2)gene [J]. Biochim Biophys Acta,2001,1520(3):234-241.
  • 4Diestra JE, Scheffer GL, Catala I, et al. Frequent expression of the multidrug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material [J]. J Pathol,2002,198(2):213-219.
  • 5Ejendal, Hrycyna CA. Multidrug resistance and cancer : the role of the human ABC transporter ABCG2 [J]. Curr Protein Pept Sci, 2002,3(5): 503-511.
  • 6Ian FF, Petra M, Marc M, et al. Expression of the breast cancer resistance protein in breast cancer[J]. Clin Cancer Res ,2002 ,8(4):1068-1074.
  • 7Imai Y, Tsukahara S, Ishikawa E, et al. Estrone and 17betaestradiol reverse breast cancer resistance protein-mediated multidrug resistance[J]. Jpn J Cancer Res, 2002,93(3):231-235.
  • 8Van den Heuvel-Eibrink MM, Wiemer EA, Prins A, et al.Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML) [J]. Leukemia,2002,16(5):833-839.
  • 9Steinbach D, Sell W, Voigt A, et al. BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia [J]. Leukemia,2002,16(8):1443-1447.
  • 10Litman T, Jensen U, Hansen A, et al. Use of peptide antibodies to probe for the mitocantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2[J]. Biochim Biophys Acta, 2002,1565(1):6.

共引文献27

同被引文献12

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部